Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson’s Disease: Preclinical and Clinical Studies
Chien‐Tai Hong, Lung Chan, Kai‐Yun Chen, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3468-3468
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
Brian Bicknell, Ann Liebert, Thomas J. Borody, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9577-9577
Open Access | Times Cited: 68
Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
Yuanyuan Ma, Xin Li, Jin‐Tai Yu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Effects of microbiome-based interventions on neurodegenerative diseases: a systematic review and meta-analysis
Zara Siu Wa Chui, Lily Man Lee Chan, Esther Wan Hei Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Berberine alleviates enterotoxigenic Escherichia coli-induced intestinal mucosal barrier function damage in a piglet model by modulation of the intestinal microbiome
Min Du, Xinran Liu, Xu Ji, et al.
Frontiers in Nutrition (2025) Vol. 11
Open Access | Times Cited: 1
Blood-brain Barrier and Neurovascular Unit Dysfunction in Parkinson's Disease: From Clinical Insights to Pathogenic Mechanisms and Novel Therapeutic Approaches
Sarah Lei Qi Khor, Khuen Yen Ng, Rhun Yian Koh, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 3, pp. 315-330
Closed Access | Times Cited: 15
Mitigation of maternal fecal microbiota transplantation on neurobehavioral deficits of offspring rats prenatally exposed to arsenic: Role of microbiota-gut-brain axis
Qian Zhao, Yan Hao, Xiaoqian Yang, et al.
Journal of Hazardous Materials (2023) Vol. 457, pp. 131816-131816
Closed Access | Times Cited: 14
The blood-brain barrier, a key bridge to treat neurodegenerative diseases
Zhongci Hang, Liping Zhou, Cencan Xing, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102070-102070
Closed Access | Times Cited: 14
Berberine alleviates ETEC-induced intestinal inflammation and oxidative stress damage by optimizing intestinal microbial composition in a weaned piglet model
Yue Wang, Z. Zhang, Min Du, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Gut Dysbiosis and Blood-Brain Barrier Alteration in Hepatic Encephalopathy: From Gut to Brain
Ali Shahbazi, Ali Sepehrinezhad, Edris Vahdani, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1272-1272
Open Access | Times Cited: 11
A neutral polysaccharide from Persicaria hydropiper (L.) Spach ameliorates lipopolysaccharide-induced intestinal barrier injury via regulating the gut microbiota and modulating AKT/PI3K/mTOR and MAPK signaling pathways
Xuanxuan Cheng, Yuehua Zhu, Jiahuan Huang, et al.
Journal of Ethnopharmacology (2023) Vol. 320, pp. 117403-117403
Closed Access | Times Cited: 11
Comparison of short-term and long-term effects of peroral L-carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications
Harsahaj Singh Wilkhoo, Felcia Reji, A. K. M. R. Islam, et al.
(2025)
Closed Access
Correlations Between Amelioration of Rotenone-Induced Parkinson’s Symptoms by Amomum tsaoko Flavonoids and Gut Microbiota in Mice
Liu Li, Yan Zhao, Weixing Yang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1676-1676
Open Access
Whole Genome Analysis of Pediococcus acidilactici XJ-24 and Its Role in Preventing Listeria monocytogenes ATCC® 19115TM Infection in C57BL/6 Mice
Weizhong Hu, Shuxin Zhou, Amel Ibrahim, et al.
Antibiotics (2025) Vol. 14, Iss. 3, pp. 323-323
Open Access
What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson’s Disease?
Jinsong Xue, Keju Tao, Weijia Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1641-1641
Open Access | Times Cited: 3
The Effect of Gut Microbiota-Targeted Interventions on Neuroinflammation and Motor Function in Parkinson’s Disease Animal Models—A Systematic Review
Paul-Ștefan Panaitescu, Vlad Răzniceanu, Ștefania-Maria Mocrei-Rebrean, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 3946-3974
Open Access | Times Cited: 3
The interplay between gut microbiota and the brain-gut axis in Parkinson’s disease treatment
Xi Jia, Qin Wang, Meilingzi Liu, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 3
The Gut Microbiome-Neuroglia Axis: Implications for Brain Health, Inflammation, and Disease
Josué Camberos-Barraza, Alma Marlene Guadrón‐Llanos, Alberto K. De la Herrán-Arita
Neuroglia (2024) Vol. 5, Iss. 3, pp. 254-273
Open Access | Times Cited: 3
The Role of Microbial Metabolites in the Progression of Neurodegenerative Diseases—Therapeutic Approaches: A Comprehensive Review
Jorge Missiego-Beltrán, Ana Isabel Beltrán-Velasco
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10041-10041
Open Access | Times Cited: 3
Novel therapeutic effects of rifaximin in combination with methylprednisolone for LPS-induced ‎oxidative stress and inflammation in mice‎: ‎an in vivo study
Marwa Salih Al-Naimi, Ahmed R. Abu‐Raghif, Hayder Adnan Fawzi
Toxicology Reports (2024) Vol. 13, pp. 101808-101808
Open Access | Times Cited: 3
The role of the gut microbiome and brain-liver-gut Axis in neurological disorders
Pan Li, Lizheng Xie, W.-C. Yang, et al.
Burns & Trauma (2025) Vol. 13
Open Access
Rifaximin Ameliorates Loperamide-Induced Constipation in Rats through the Regulation of Gut Microbiota and Serum Metabolites
Mei Luo, Peiwei Xie, Xuehong Deng, et al.
Nutrients (2023) Vol. 15, Iss. 21, pp. 4502-4502
Open Access | Times Cited: 7
Gut-directed therapy in Parkinson’s disease
Laura Benvenuti, Clelia Di Salvo, Gabriele Bellini, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Polysaccharides extracted from common buckwheat (Fagopyrum esculentum) attenuate cognitive impairment via suppressing RAGE/p38/NF-κB signaling and dysbiosis in AlCl3-treated rats
Yuchen Liu, Shengyi Chen, Yingying Chen, et al.
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 133898-133898
Closed Access | Times Cited: 2
The gut-brain axis in Parkinson's disease
Bruno Bonaz
Revue Neurologique (2023) Vol. 180, Iss. 1-2, pp. 65-78
Closed Access | Times Cited: 6
Antimicrobial drugs for Parkinson’s disease: existing therapeutic strategies and novel drugs exploration
Mengjie Fu, Qiuchen Wang, Lihui Gao, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102387-102387
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top